|
References
1. Innocenti M,
Moscatelli, G, Lopez, S. Efficacy of Gelclair in Reducing Pain in Patients
with Oral Lesions: Preliminary Findings From an Open Pilot Study. Journal
of Pain and Symptom Management 2002; 24(5): 456-457.
2. De Cordi, D, Martina, S. Gelclair: potentially an
efficacious treatment for chemotherapy-induced mucositis. Presented at
the Italian Tumour League III congress for professional oncology nurses,
Conegliano, Italy, 10-12 October 2001.
3. Berndtson M. A Preliminary Study of Orassist (Gelclair)
in the management of Oral Mucositis. This paper was published in Svensk
Sjukhustandlakartidning (Swedish Hospital Dentistry) 2001 Nr 3 (Argang
26): 17-21.
4. Smith T, Gelclair: managing the symptoms of oral mucositis.
Hospital Medicine, 2001;62 (10): 623-626.
5. Rubenstein E et al. Clinical practice guidelines for the
prevention and treatment of cancer therapy-induced oral and gastrointestinal
mucositis. American cancer soc. 2004: 2026-2046.
6. Sonis S et al. Oral Mucositis and the clinical and economic
outcomes of hematopoietic stem –cell transplantation. J Clin Oncol. 2001;
19: 2201-2205.
7. Elting L et al. The burdens of cancer therapy. Cancer
2003; 98: 1531-1539.
• Who
can use Gelclair?
• What
problems do oral lesions cause?
• How
can Gelclair help?
• Further
Information
• References
|
|